A5082058728- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- Vibrio bacteria research studies
- Microplastics and Plastic Pollution
- Acute Myeloid Leukemia Research
- Cancer Genomics and Diagnostics
- Hepatitis C virus research
- Hepatitis B Virus Studies
- COVID-19 Clinical Research Studies
- Natural Fiber Reinforced Composites
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Biosensors and Analytical Detection
Universidade de São Paulo
2024
Hospital Israelita Albert Einstein
2021-2023
Abstract Since the first reported case of new coronavirus infection in Wuhan, China, researchers and governments have witnessed an unseen rise number cases. Thanks to rapid work Chinese scientists, pathogen now called SARS-CoV-2 has been identified its whole genome was deposited public databases by early January 2020. The availability allowed develop Reverse Transcription—Polymerase Chain Reaction (RT-PCR) assays, which are gold-standard for molecular diagnosis respiratory syndrome COVID19....
During the COVID-19 pandemic, a case of long-term persistence SARS-CoV-2 infection (from March 26 to May 20, 2020) was identified at private hospital in São Paulo, SP, Brazil. The positivity for reverse transcriptase polymerase chain reaction tests patient diagnosed with suggests, least part patients who recovered, may still carry and transmit virus. This fact emphasizes importance having two negative test results SARS-CoV-2. Serological assays were not particularly helpful described, since...
Hepatitis B Virus is classified into ten different genotypes (A- J). Genotypes F and H cluster apart from others in phylogenetic trees particularly frequent the Americas. The aim of this study was to sequence complete genomes samples HBV Brazil Mexico using next generation sequencing (NGS) relevant characteristics for disease associated with virus.Ninety plasma detectable DNA belonging (n=59) (n=31) were submitted amplification genome by three methologies. Data analysis developed...